PharmaCyte Biotech
PMCB
PMCB
28 hedge funds and large institutions have $712K invested in PharmaCyte Biotech in 2025 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
Holders
28
Holding in Top 10
–
Calls
$391K
Puts
–
Top Buyers
| 1 | +$194K | |
| 2 | +$165K | |
| 3 | +$90K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$22.3K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$22.1K |
Top Sellers
| 1 | -$54.5K | |
| 2 | -$2.48K | |
| 3 | -$588 | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$202 |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$20 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MA
26
MCF Advisors
Covington,
Kentucky
| $1 |
|
|||
27
Citigroup
New York
| – |
|